The STING pathway targeting technologies market is anticipated to be worth over USD 2.8 billion by 2030, predicts Roots Analysis
STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy and is being pursued by several large pharmaceutical companies   Roots Analysis is pleased to announce the publication of its recent study, titled, “STING Pathway Targeting Therapeutics and Technologies,...
0 Comments 0 Shares
Sponsored